Is breast implant illness a real, recognized medical diagnosis?

Breast implant illness (BII) is a term patients use to describe a cluster of systemic symptoms they attribute to their implants, and the FDA acknowledges these reports in its official labeling requirements. However, BII is not currently a formally defined medical diagnosis with established diagnostic criteria the way BIA-ALCL is — research into a causal mechanism is ongoing, and this distinction is important to understand clearly.

What's the difference between BII and BIA-ALCL?

BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) is a rare, well-defined cancer of the immune system with established diagnostic tests and a known, though not fully understood, association with certain textured implants. BII refers to a broader set of patient-reported systemic symptoms without an established diagnostic test or confirmed causal mechanism. These are two distinct issues and should never be conflated.

Does removing implants cure BII symptoms?

Some patients report improvement or resolution of symptoms after explant surgery, and this is acknowledged in FDA patient communications, but not all patients experience improvement, and there is no guarantee of symptom resolution. This should be discussed as a possibility, not a promised outcome, before deciding on explant surgery.

What is 'en bloc' capsulectomy and is it necessary?

En bloc capsulectomy removes the implant together with its surrounding scar tissue capsule as a single, intact unit, and some patients specifically request it believing it improves symptom resolution. This remains a debated point among surgeons without a clear evidence-based consensus on whether it's necessary for BII specifically, versus standard capsule removal — it's a conversation to have directly with a qualified surgeon rather than assuming one approach is definitively superior.

What are the symptoms people associate with breast implant illness?

Commonly reported symptoms include fatigue, joint and muscle pain, brain fog, rashes, and hair loss, among others. These symptoms are real and should be taken seriously by patients and physicians alike, even though a specific causal link to implants has not been scientifically established.

What should I do if I think I have breast implant illness?

Start with a thorough medical evaluation to rule out other, unrelated causes of your symptoms, since fatigue, joint pain, and similar complaints can stem from many conditions unrelated to implants. If other causes are ruled out and symptoms persist, discuss your full history and options — including explant surgery — with both your primary care physician and a board-certified plastic surgeon.

Breast Implant Illness (BII): What the Evidence Shows

Few topics in cosmetic surgery require as much care in how they're discussed as breast implant illness. Patients experiencing real, often debilitating symptoms deserve to be taken seriously and not dismissed — and at the same time, honest reporting requires being clear about what current scientific evidence does and does not establish. This page aims to hold both of those things at once, without minimizing patient experience or overstating unproven causation.

What People Report

Patients who describe breast implant illness commonly report a cluster of symptoms including persistent fatigue, joint and muscle pain, "brain fog" or cognitive difficulty, rashes and skin changes, hair loss, dry eyes and mouth, and, in some cases, symptoms resembling autoimmune conditions. These experiences are frequently reported to be significant and disruptive to daily life, and FDA-mandated patient materials for breast implants now explicitly acknowledge that patients have reported this range of systemic symptoms.¹ Taking these reports seriously as a starting point for evaluation — rather than dismissing them outright — is the appropriate clinical approach.

What Research Says So Far

Here is where honesty about the state of the evidence matters most: despite substantial patient-reported experience, a specific, scientifically established causal mechanism linking breast implants to this symptom cluster has not been confirmed. Researchers continue to study potential biological pathways — including possible immune system responses to implant materials — but as of current published research, BII does not have an agreed-upon diagnostic test, defined diagnostic criteria, or confirmed mechanism the way many other medical conditions do. This is genuinely different from saying the symptoms aren't real or that patients are imagining them; it means the specific causal link to implants, as opposed to other possible explanations, remains scientifically unresolved. Breast augmentation remains one of the most commonly performed cosmetic procedures in the US, which is one reason patient-reported symptom clusters receive ongoing regulatory and research attention rather than being dismissed.³ Ongoing research, including post-approval studies mandated by the FDA, continues to track this question.¹

The FDA's current Medical Device Report summary lists 10,318 reports describing systemic symptoms in patients with breast implants from January 2008 through June 30, 2024.⁴ This number should not be read as an incidence rate or proof of causation: the reporting system is passive, reports may be incomplete or duplicated, and the total number of implanted patients represented by the reporting period is unknown. The data are useful as a safety signal and a reason for continued investigation, not as a denominator-based estimate of how often symptoms occur.

This uncertainty changes how individual stories should be interpreted. Improvement after removal is meaningful for the patient who experiences it, but one person's response cannot establish which part of the operation produced the change or predict another patient's outcome. Symptoms can fluctuate over time, multiple treatments may occur together, and published studies use different definitions of improvement. The most responsible summary is therefore neither “implants cannot cause symptoms” nor “removal will cure them,” but that reported improvement and unresolved causation can both be true at the present stage of evidence.

FDA Guidance & Implant Labeling (BIA-ALCL, Clearly Distinguished from BII)

It's essential not to conflate two genuinely different issues that both appear in breast implant safety discussions. BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) is a rare but well-defined and confirmed cancer of the immune system, most commonly diagnosed via fluid or tissue analysis around the implant, with an established association with certain textured implant surfaces — professional consensus guidelines describe BIA-ALCL as a distinct lymphoma entity linked primarily to textured implants, with defined diagnostic pathways and treatment protocols.² Some patients have died from BIA-ALCL, and the FDA has taken specific regulatory action, including restricting implant sales to facilities that provide mandated risk-communication materials to patients.¹ BII is a separate, broader category of patient-reported systemic symptoms without an equivalent diagnostic test or confirmed mechanism. Current FDA-mandated patient labeling requires disclosure of both issues — the confirmed BIA-ALCL risk and the reported-but-unconfirmed BII symptom pattern — as part of informed consent before implant surgery, but the two remain distinct in evidence status and should always be discussed separately, not blended together in either direction.

Explant Surgery: What It Involves

Explant surgery removes breast implants, and is sometimes requested by patients experiencing symptoms they attribute to their implants, regardless of whether a specific causal mechanism has been confirmed. The surgery can be performed with or without removing the surrounding scar tissue capsule; when the capsule is removed intact together with the implant as a single unit, this is referred to as "en bloc" capsulectomy. Some patients specifically request the en bloc approach believing it improves the odds of symptom resolution, but this remains a genuinely debated point among surgeons — there isn't a clear, evidence-based consensus establishing en bloc removal as necessary or more effective for BII symptom resolution specifically, as opposed to standard capsule management. FDA patient materials note that some patients report improvement or resolution of symptoms after implant removal, but explicitly do not guarantee this outcome for every patient.¹ Anyone considering explant surgery for symptom relief should have a direct, unhurried conversation with their surgeon about realistic likelihood of improvement, not an assumption of guaranteed relief. For more detail on the removal process itself, see our breast implant removal guide.

If You're Experiencing Symptoms — What to Do

If you have breast implants and are experiencing symptoms like the ones described above, the appropriate first step is a thorough medical evaluation — not with the assumption that implants are automatically the cause, but to properly rule out other, unrelated conditions that can produce similar symptoms, since fatigue, joint pain, and brain fog have many possible causes unrelated to implants. If other causes are ruled out through appropriate testing and the symptom picture and timeline are consistent with your implant history, discuss your full case, including the possibility of explant surgery, with both your primary care physician and a board-certified plastic surgeon. The FDA also encourages reporting implant-related health issues through its MedWatch program, which helps build the broader evidence base researchers rely on. For guidance specifically on breast implants as a procedure, see our breast implants overview.

Prepare for that evaluation by documenting when symptoms began, whether they fluctuate, medications and supplements used, previous diagnoses, implant type, surface, and placement date, and any prior imaging or implant-card information. A timeline helps clinicians investigate other explanations and gives an explant consultation a more useful baseline. If removal is considered, ask separately about implant-only removal, partial or total capsulectomy, the additional risks of each approach, likely cosmetic change, and how improvement would be assessed afterward. Shared decision-making is especially important when the evidence cannot promise a specific symptom outcome.

Keep copies of test results and consultation notes so each clinician is working from the same record.

Frequently Asked Questions

Is breast implant illness a real, recognized medical diagnosis?
Breast implant illness (BII) is a term patients use to describe a cluster of systemic symptoms they attribute to their implants, and the FDA acknowledges these reports in its official labeling requirements. However, BII is not currently a formally defined medical diagnosis with established diagnostic criteria the way BIA-ALCL is — research into a causal mechanism is ongoing, and this distinction is important to understand clearly.
What's the difference between BII and BIA-ALCL?
BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) is a rare, well-defined cancer of the immune system with established diagnostic tests and a known, though not fully understood, association with certain textured implants. BII refers to a broader set of patient-reported systemic symptoms without an established diagnostic test or confirmed causal mechanism. These are two distinct issues and should never be conflated.
Does removing implants cure BII symptoms?
Some patients report improvement or resolution of symptoms after explant surgery, and this is acknowledged in FDA patient communications, but not all patients experience improvement, and there is no guarantee of symptom resolution. This should be discussed as a possibility, not a promised outcome — see our breast implant removal guide for what the surgery involves.
What is "en bloc" capsulectomy and is it necessary?
En bloc capsulectomy removes the implant together with its surrounding scar tissue capsule as a single, intact unit, and some patients specifically request it believing it improves symptom resolution. This remains a debated point among surgeons without a clear evidence-based consensus on whether it's necessary for BII specifically — it's a conversation to have directly with a qualified surgeon.
What are the symptoms people associate with breast implant illness?
Commonly reported symptoms include fatigue, joint and muscle pain, brain fog, rashes, and hair loss, among others. These symptoms are real and should be taken seriously by patients and physicians alike, even though a specific causal link to implants has not been scientifically established.
What should I do if I think I have breast implant illness?
Start with a thorough medical evaluation to rule out other, unrelated causes of your symptoms, since fatigue, joint pain, and similar complaints can stem from many conditions unrelated to implants. If other causes are ruled out and symptoms persist, discuss your full history and options — including explant surgery — with both your primary care physician and a board-certified plastic surgeon.

Breast Implant Illness (BII): What the Evidence Currently Shows